Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

The treatment is safe and shows promise for metastatic breast cancer.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Individualized homeopathic treatment with Lycopodium clavatum may help manage alopecia areata and improve related emotional symptoms.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

A mare had severe symptoms and died from a large lymphoma.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Skin problems are common in lupus patients and should be treated early to prevent worsening.